Genetically engineered AD models, primarily based on the overexpression of presinilin1 or APP mutant human genes causing early-onset Familial AD (FAD), are used to study hallmark behavioral and neuropathological mechanisms of SAD, the sporadic and most common form of Alzheimer’s disease despite some gaps [53,54]. The gene discussed is APP; the disease is Alzheimer disease.